Work

Long-Term Neurocognitive Effects of Olanzapine or Low-Dose Haloperidol in First-Episode Psychosis

Year: 2005

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Biological Psychiatry

DOI: 10.1016/j.biopsych.2005.06.022

Authors: Richard S.E. Keefe, Larry J. Seidman, Bruce K. Christensen, Robert M. Hamer, Tonmoy Sharma, Margriet M. Sitskoorn, Stephanie L. Rock, Sandra Woolson, Mauricio Tohen, Gary D. Tollefson, Todd M. Sanger, Jeffrey A. Lieberman

Institutions: Duke University, Duke Medical Center, Harvard University, University of Toronto, University of North Carolina at Chapel Hill, University Medical Center Utrecht, Eli Lilly (United States), Indiana University School of Medicine, Columbia University

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Pfizer, GlaxoSmithKline, Sanofi

OpenAlex ID: W2076477832

FWCI: 6.231

Cites: 62

Cited by: 121

Related to: 10